Nasal mucosa blood vessels

The nasal mucosa blood vessels represent a specialized vascular network consisting of arterioles, capillaries, and large venous sinusoids, often referred to as capacitance vessels, which play a vital role in warming and humidifying inhaled air [5, 13]. These vessels are the primary physiological site of action for nasal decongestants used to treat symptoms of allergic rhinitis and upper respiratory tract infections [1, 7]. The therapeutic effect is mediated by molecular targets located within the vessel walls, specifically Alpha-1 and Alpha-2 adrenergic receptors, which, when activated by sympathomimetic agonists, induce smooth muscle contraction and significant vasoconstriction [4, 11]. This reduction in vascular volume decreases mucosal swelling and airway resistance, providing immediate relief from nasal congestion [3, 10]. However, these vessels also respond to inflammatory mediators such as histamine and leukotrienes, which promote vasodilation and increased vascular permeability during allergic reactions [8, 14]. Chronic pharmacological manipulation of this site can lead to safety concerns such as rhinitis medicamentosa, characterized by rebound congestion and potential mucosal atrophy [8, 10].

Other names

Nasal vasculatureNasal mucosal blood vesselsCapacitance vessels of the nasal mucosaNasal venous sinusoids

Drugs targeting this site typically function as agonists of Alpha-1 and Alpha-2 adrenergic receptors located on the vascular smooth muscle. Activation of these receptors leads to vasoconstriction, which reduces the volume of the nasal venous sinusoids and decreases interstitial edema, thereby widening the nasal passages.